887
Participants
Start Date
August 22, 2022
Primary Completion Date
December 29, 2023
Study Completion Date
December 29, 2023
Peking University People's Hospital, Beijing
Research Site, Beijing
Research Site, Dalian
Research Site, Dongyang
Research Site, Hangzhou
Research Site, Hefei
Research Site, Jinan
Research Site, Kaifeng
Research Site, Ningbo
Research Site, Qingdao
Research Site, Shijiazhuang
Research Site, Tianjin
Research Site, Xuzhou
Research Site, Yangzhou
Research Site, Zhangjiagang
Research Site, Zhengzhou
Lead Sponsor
AstraZeneca
INDUSTRY